Director/PDMR Shareholding

RNS Number : 5686J

GlaxoSmithKline PLC

17 July 2013

 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan notified the Company and the under-mentioned persons on 17 July 2013 of the following increases in their notional interests in Ordinary Shares at a price of 1742.50 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $52.91 per ADS following the notional re-investment of the dividend paid to shareholders on 11 July 2013.

	Ordinary Shares	ADSs
Sir Andrew Witty	15,933.601
Dr M M Slaoui		5,063.622
Mr S Dingemans	6,179.375
Mr S M Bicknell	1,671.475
Mr R G Connor	1,108.212
Mrs D P Connelly		2,136.181
Mr S A Hussain	4,862.837
Mr W C Louv		1,475.514
Mr D S Redfern	2,387.819
Ms C Thomas	3,318.703
Mr P C Thomson	1,053.777
Mr D E Troy		2,845.809
Dr P J T Vallance	5,496.616
Ms E Walmsley	3,121.039
Mr C Weber	778.922
Mrs V A Whyte	391.310

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

17 July 2013

 

END

 

 

RDSQDLFFXDFFBBX